logo
Breadcrumbs Image

Personalized Medicine Market

Personalized Medicine Market

Global Personalized Medicine Market Research Report 2021 Professional Edition


Date: Apr-2021 | Id: MACRC-40278 | Geographical Scope: Global | Publisher: HNY Research

The research team projects that the Personalized Medicine market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited

By Type
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness

By Application
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Personalized Medicine 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Personalized Medicine Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Personalized Medicine Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Personalized Medicine market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Personalized Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Personalized Medicine Diagnostics
1.4.3 Personalized Medical Care
1.4.4 Personalized Medicine Therapeutics
1.4.5 Personalized Nutrition and Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicine Market Share by Application: 2022-2027
1.5.2 Oncology
1.5.3 Central Nervous System (CNS)
1.5.4 Immunology
1.5.5 Respiratory
1.5.6 Other Applications
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Personalized Medicine Market
1.8.1 Global Personalized Medicine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Personalized Medicine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Personalized Medicine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Personalized Medicine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Personalized Medicine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Personalized Medicine Sales Volume Market Share by Region (2016-2021)
3.2 Global Personalized Medicine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Personalized Medicine Sales Volume
3.3.1 North America Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Personalized Medicine Sales Volume
3.4.1 East Asia Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Personalized Medicine Sales Volume (2016-2021)
3.5.1 Europe Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Personalized Medicine Sales Volume (2016-2021)
3.6.1 South Asia Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Personalized Medicine Sales Volume (2016-2021)
3.7.1 Southeast Asia Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Personalized Medicine Sales Volume (2016-2021)
3.8.1 Middle East Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Personalized Medicine Sales Volume (2016-2021)
3.9.1 Africa Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Personalized Medicine Sales Volume (2016-2021)
3.10.1 Oceania Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Personalized Medicine Sales Volume (2016-2021)
3.11.1 South America Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Personalized Medicine Sales Volume (2016-2021)
3.12.1 Rest of the World Personalized Medicine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Personalized Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Personalized Medicine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Personalized Medicine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Personalized Medicine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Personalized Medicine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Personalized Medicine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Personalized Medicine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Personalized Medicine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Personalized Medicine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Personalized Medicine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Personalized Medicine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Personalized Medicine Sales Volume Market Share by Type (2016-2021)
14.2 Global Personalized Medicine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Personalized Medicine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Personalized Medicine Consumption Volume by Application (2016-2021)
15.2 Global Personalized Medicine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Personalized Medicine Business
16.1 Abbott Laboratories
16.1.1 Abbott Laboratories Company Profile
16.1.2 Abbott Laboratories Personalized Medicine Product Specification
16.1.3 Abbott Laboratories Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Agilent Technologies
16.2.1 Agilent Technologies Company Profile
16.2.2 Agilent Technologies Personalized Medicine Product Specification
16.2.3 Agilent Technologies Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Amgen
16.3.1 Amgen Company Profile
16.3.2 Amgen Personalized Medicine Product Specification
16.3.3 Amgen Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Astellas Pharma
16.4.1 Astellas Pharma Company Profile
16.4.2 Astellas Pharma Personalized Medicine Product Specification
16.4.3 Astellas Pharma Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Astrazeneca
16.5.1 Astrazeneca Company Profile
16.5.2 Astrazeneca Personalized Medicine Product Specification
16.5.3 Astrazeneca Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Bayer AG
16.6.1 Bayer AG Company Profile
16.6.2 Bayer AG Personalized Medicine Product Specification
16.6.3 Bayer AG Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Celgene Corporation
16.7.1 Celgene Corporation Company Profile
16.7.2 Celgene Corporation Personalized Medicine Product Specification
16.7.3 Celgene Corporation Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Glaxosmithkline Plc
16.8.1 Glaxosmithkline Plc Company Profile
16.8.2 Glaxosmithkline Plc Personalized Medicine Product Specification
16.8.3 Glaxosmithkline Plc Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Illumina
16.9.1 Illumina Company Profile
16.9.2 Illumina Personalized Medicine Product Specification
16.9.3 Illumina Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Johnson & Johnson
16.10.1 Johnson & Johnson Company Profile
16.10.2 Johnson & Johnson Personalized Medicine Product Specification
16.10.3 Johnson & Johnson Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Laboratory Corporation
16.11.1 Laboratory Corporation Company Profile
16.11.2 Laboratory Corporation Personalized Medicine Product Specification
16.11.3 Laboratory Corporation Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Merck
16.12.1 Merck Company Profile
16.12.2 Merck Personalized Medicine Product Specification
16.12.3 Merck Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Novartis AG
16.13.1 Novartis AG Company Profile
16.13.2 Novartis AG Personalized Medicine Product Specification
16.13.3 Novartis AG Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Roche Holding AG
16.14.1 Roche Holding AG Company Profile
16.14.2 Roche Holding AG Personalized Medicine Product Specification
16.14.3 Roche Holding AG Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Siemens AG
16.15.1 Siemens AG Company Profile
16.15.2 Siemens AG Personalized Medicine Product Specification
16.15.3 Siemens AG Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Takeda Pharmaceutical Company Limited
16.16.1 Takeda Pharmaceutical Company Limited Company Profile
16.16.2 Takeda Pharmaceutical Company Limited Personalized Medicine Product Specification
16.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Personalized Medicine Manufacturing Cost Analysis
17.1 Personalized Medicine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Personalized Medicine
17.4 Personalized Medicine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Personalized Medicine Distributors List
18.3 Personalized Medicine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Personalized Medicine (2022-2027)
20.2 Global Forecasted Revenue of Personalized Medicine (2022-2027)
20.3 Global Forecasted Price of Personalized Medicine (2016-2027)
20.4 Global Forecasted Production of Personalized Medicine by Region (2022-2027)
20.4.1 North America Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.9 South America Personalized Medicine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Personalized Medicine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Personalized Medicine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Personalized Medicine by Country
21.2 East Asia Market Forecasted Consumption of Personalized Medicine by Country
21.3 Europe Market Forecasted Consumption of Personalized Medicine by Countriy
21.4 South Asia Forecasted Consumption of Personalized Medicine by Country
21.5 Southeast Asia Forecasted Consumption of Personalized Medicine by Country
21.6 Middle East Forecasted Consumption of Personalized Medicine by Country
21.7 Africa Forecasted Consumption of Personalized Medicine by Country
21.8 Oceania Forecasted Consumption of Personalized Medicine by Country
21.9 South America Forecasted Consumption of Personalized Medicine by Country
21.10 Rest of the world Forecasted Consumption of Personalized Medicine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Add to Cart

Single User

$ 2890.00

Site License

$ 4335.00

Enterprisewide

$ 5780.00